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Drug companies do everything they can to sell 
their products. This, in itself, is not surprising. After 
all, that’s what businesses do. But do we really 
know what drug companies do and the extent of 
their influence? After reading Sergio Sismondo’s 
book Ghost-Managed Medicine, we realised we 
knew only a fraction of what is really happening. 
Sismondo exposes pharmaceutical companies’ 
extensive involvement in knowledge produc-
tion.  His arguments are compelling. Yes, one can 
read about how corporate-funded research tends 
towards publishing only favourable results, and 
about the fancy hotels and bonusses doctors 
receive when promoting the company’s products. 
But this is not what the book is about. What Ghost-
Managed Medicine is really about is the invisible 
(‘ghost’) orchestration (‘managed’) of medical 
knowledge production by the pharmaceutical 
industry. 
This focus and scope of the book positions it 
in a strong STS tradition of opening the black box 
of the construction of scientific facts. Sismondo 
convincingly demonstrates how industry is 
involved in all aspects of medical knowledge 
production, circulation and consumption. Consid-
ering the secretive character of corporate activi-
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ties, it is impressive how the author has found his 
way into their political economies of knowledge 
production. Since many of company activities 
are outsourced and have to be promoted to their 
target groups (physicians) there is a highly-devel-
oped infrastructure of communication. It is in 
these promotion and educational meetings that 
Sismondo undertook ethnographic research. On 
the basis of this data he describes in detail what 
he calls ‘assemblage marketing’: how “a pharma-
ceutical company creates a market by producing, 
shaping and transporting research and medical 
journal articles, as well as opinion leaders and 
patient advocates. It pushes these in the expec-
tation of influencing regulators, physicians, 
patients and other useful actors” (p. 23). Reading 
the book, it becomes clear how the pharmaceu-
tical industry not only finance medical trials but 
are also involved in their design, in running the 
trials, undertaking the statistical analysis, writing 
the articles, selecting the journals and at the 
very end of the process inviting a well-known 
academic researcher to author the publica-
tion. This last move makes it almost impossible 
to distinguish the result from other academic 
research. Sismondo stresses that this in itself does 
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not imply scientific flaws. The problem lies in the 
fact that scientific knowledge is entirely imbued 
with corporate interests that have been compre-
hensively removed from view. Research, in other 
words, acts as a Trojan horse for marketing. 
However, the activities of drug companies 
do not stop here. Going beyond ghost-writing, 
Sismondo reveals how drug companies exert 
their influence in continuing medical education, 
through the co-opting and manipulation of ‘key 
opinion leaders’. In some cases, drug companies 
even market symptoms and syndromes, initially 
in an ‘unbranded’ campaign, and as such shape 
public views of what to consider as healthy and 
unhealthy. Once need for a remedy is estab-
lished, the product waiting in the wings can 
then quickly take centre stage. In this way drug 
companies penetrate doctors’ consulting rooms, 
hospital wards, patient associations, and enter the 
thought-processes of patients.
The strength of this book lies in the detailed 
analysis of pharmaceutical companies’ strate-
gies of control over medical knowledge produc-
tion – these are pervasive and unremitting, even 
to the point of aligning journal editors’ interests 
with those of pharmaceutical companies. No 
stone is left unturned. The result is to completely 
undermine any semblance of objectivity in 
research and individual agency of doctors – both 
highly valued concepts in medicine. Where the 
book is weaker is in relation to the tactics of sales 
representatives. This chapter confirms suspicions 
but does not take our understanding beyond what 
one might expect. Nevertheless, we would like to 
suggest that ‘doctors-to-be’ should become aware 
of these processes. Being involved in the training 
of medical doctors and medical researchers we, 
Jessica Mesman and Dawn Goodwin, think that 
Ghost-Managed Medicine is an important text for 
students for the following reasons. Sismondo’s 
book provides the means with which to teach 
students in the field of medicine core STS insights 
about the influences of the wider social and 
cultural context in which scientific knowledge 
is produced. The book illustrates the different 
relations between science and society, laying out 
in particular the role of industry and its complex 
and far-reaching influence. In this way, doctors-
to-be and those who pursue a career in medical 
research become aware of corporate challenges 
to independence and the mechanisms through 
which industry exerts its influence in medical 
knowledge production on macro-, meso- and 
micro-levels. The book does all this with limited 
reference to sociological concepts and termi-
nology. The connections to sociological bodies 
of work are clearly evident to those who would 
recognise them, and are explained explicitly in 
the opening chapter, but then the book speaks 
directly and plainly – an enormous benefit when 
teaching students who are required to develop 
social science understandings but without social 
science backgrounds.
To road test our view, we asked two students 
- Pierre Springuel and Sean Jensen – for their 
opinions:
Reading ‘Ghost-managed medicine’, for the 
first time in our careers, shed light on the 
pharmaceutical industry’s veiled involvement in 
nearly all aspects of medical sciences. It describes 
the various interventions, hidden agendas and 
parties of the industrial machine involved in 
the creation, distribution and uptake of medical 
information. With responsibility as paramount 
as health, these supposed directors of our well-
being are heavily scrutinised and approached with 
scepticism, we were keen to explore the extent 
to which this scrutiny and scepticism could be 
justified. 
Reading the book, we were quickly faced with the 
reality that pharmaceutical companies control 
a significant portion of the information that 
professionals and public alike can access. Methods 
range from data manipulation, ghost-writing and 
public censorship to the recruitment of prestigious 
clinicians, researchers and communication 
companies to mindlessly parrot pharmaceutical 
agendas. To our dismay, it became blatantly evident 
we were ignorant of these ongoing practices, 
especially as biomedical students destined to one 
day become actors on Big Pharma’s stage. 
These crafty and manipulative conducts need to 
be recognised by the general public, and especially 
by future medical practitioners and researchers 
who often unknowingly act as marionettes of the 
pharmaceutical industry. We feel that the way 
to most effectively integrate this reality for the 
benefit of both the public and the industries is 
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for attention to be brought on these issues. We 
believe this to be especially important for the next 
generation of scientists in the medical industry - us.
We advocate open discussion of the complicated 
issues brought up by Sismondo in small group 
seminars. There are no simple answers to the 
ethical concerns that arise with the pharmaceutical 
industry’s influence, and so discussion is key. 
Discussing these matters in a critical manner, 
dissecting the problems and potential solutions, 
not only exposes but educates students on the 
current workings. The point of discussion is not 
to “solve the issue”, but to critically evaluate 
arguments so that we can be aware and hopefully 
make well-informed decisions. We believe this to 
be the best way to equip students with the tools 
necessary to act in a more ethical manner when 
challenged by exogenous pressures. 
So students and tutors agree – this book holds 
important lessons for future medical practitioners 
and researchers, those who value the objectivity 
of medical research and their independence as 
decision-makers. 
